Target intelligence / Profile preview

HTH-type transcriptional regulator QacR (QacR) (QacR)

Target
QacR
Molecular classification
Transcription factor, TetR family repressor, DNA-binding protein
01

Overview

HTH-type transcriptional regulator QacR (QacR) is a member of the TetR family of transcriptional repressors, primarily identified in Staphylococcus aureus (UniProt, 2024). It plays a pivotal role in bacterial multidrug resistance by controlling the expression of the QacA efflux pump, which exports a wide variety of toxic cationic lipophilic compounds from the cell (Grkovic et al., 1998). QacR functions by binding as a pair of dimers to the operator region of the qacA gene, thereby inhibiting its transcription under basal conditions (Schumacher et al., 2002). The protein is distinguished by an unusually large and flexible multidrug-binding pocket that can accommodate structurally diverse ligands, including quaternary ammonium disinfectants, antiseptic dyes, and plant alkaloids (Grkovic et al., 2003). When these ligands bind to QacR, they induce a coil-to-helix conformational change that reduces the protein's affinity for DNA, resulting in the derepression of qacA and the subsequent efflux of the inducing agents (Schumacher et al., 2001). As a key regulator of resistance in clinical pathogens like MRSA, QacR is a significant target for the development of antimicrobial adjuvants designed to bypass or inhibit bacterial resistance mechanisms (Tahlan et al., 2009).

Other names
HTH-type transcriptional regulator QacRqacRRepressor of qacAQuaternary ammonium compound-resistance repressor
02

Mechanism of action

QacR represses the transcription of the qacA multidrug efflux pump gene by binding to its operator sequence as a pair of dimers; binding of inducing ligands to the QacR multidrug-binding pocket triggers a conformational change that causes the protein to dissociate from DNA, thereby inducing qacA expression (Grkovic et al., 1998; Schumacher et al., 2001).

03

Biological functions

Regulation of transcriptionMultidrug resistanceEfflux pump regulationNegative regulation of DNA-templated transcription
04

Disease associations

InfectionAntimicrobial resistance
05

Safety considerations

Broad ligand specificity makes specific inhibitor design challengingPotential for rapid evolution of resistance mutations in the binding pocketRisk of cross-resistance to multiple antimicrobial classes
06

Interacting drugs

Benzalkonium chloride

10 more in the full profile.

07

Biomarkers

qacR gene presenceqacA expression levelsBacterial resistance to quaternary ammonium compounds

Beyond the preview

Go deeper on HTH-type transcriptional regulator QacR (QacR) (QacR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HTH-type transcriptional regulator QacR (QacR) (QacR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call